Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Life Sciences Industry Analysis

UpdatedJan 12, 2026
DataAggregated Company Financials
Companies9
  • 7D2.4%
  • 3M-11.6%
  • 1Y1.4%
  • YTD1.9%

Over the last 7 days, the Life Sciences industry has risen 1.9%, driven by gains from AddLife of 2.3%. Despite this gain, the industry's performance has been flat over the past year. Earnings are forecast to grow by 26% annually.

Industry Valuation and Performance

Has the Swedish Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 12 Jan 2026SEK 30.7bSEK 14.9b-SEK 744,515,427.0048x-41.3x2.1x
Wed, 10 Dec 2025SEK 32.8bSEK 14.9b-SEK 744,515,427.0054.3x-44.1x2.2x
Fri, 07 Nov 2025SEK 34.6bSEK 14.7b-SEK 742,825,012.0054x-46.5x2.3x
Sun, 05 Oct 2025SEK 34.5bSEK 14.7bSEK 61.3m58.7x562.8x2.4x
Tue, 02 Sep 2025SEK 35.3bSEK 14.7bSEK 60.9m57.8x580.6x2.4x
Thu, 31 Jul 2025SEK 36.5bSEK 14.8bSEK 186.0m59.1x196.4x2.5x
Sat, 28 Jun 2025SEK 46.7bSEK 16.6bSEK 405.8m68.5x115.1x2.8x
Mon, 26 May 2025SEK 45.0bSEK 16.6bSEK 401.3m68.5x112.2x2.7x
Wed, 23 Apr 2025SEK 41.0bSEK 16.6bSEK 580.4m44.3x70.6x2.5x
Fri, 21 Mar 2025SEK 37.3bSEK 16.6bSEK 614.9m38x60.6x2.2x
Sun, 16 Feb 2025SEK 43.7bSEK 17.0b-SEK 1,038,511,426.0042.5x-42.1x2.6x
Tue, 14 Jan 2025SEK 41.1bSEK 16.7b-SEK 1,152,911,426.0043.2x-35.6x2.5x
Thu, 12 Dec 2024SEK 44.5bSEK 16.7b-SEK 1,152,911,426.0051.4x-38.6x2.7x
Sat, 09 Nov 2024SEK 44.3bSEK 16.8b-SEK 958,019,827.0050.7x-46.3x2.6x
Mon, 07 Oct 2024SEK 47.2bSEK 16.7b-SEK 988,175,491.0058.9x-47.7x2.8x
Wed, 04 Sep 2024SEK 48.6bSEK 16.7b-SEK 987,374,492.0061.8x-49.2x2.9x
Fri, 02 Aug 2024SEK 49.2bSEK 16.7b-SEK 1,128,120,510.0061.9x-43.6x2.9x
Sun, 30 Jun 2024SEK 42.0bSEK 16.3b-SEK 1,188,686,510.0055.3x-35.3x2.6x
Tue, 28 May 2024SEK 43.1bSEK 16.3b-SEK 1,188,686,510.0061.1x-36.2x2.6x
Thu, 25 Apr 2024SEK 37.9bSEK 16.1b-SEK 1,234,732,213.0036.3x-30.7x2.4x
Sat, 23 Mar 2024SEK 38.9bSEK 16.0b-SEK 1,122,792,210.0036x-34.6x2.4x
Mon, 19 Feb 2024SEK 41.0bSEK 16.0b-SEK 1,409,735,350.0050.7x-29.1x2.6x
Wed, 17 Jan 2024SEK 36.9bSEK 15.5b-SEK 1,393,723,683.0045.2x-26.5x2.4x
Fri, 15 Dec 2023SEK 37.4bSEK 15.5b-SEK 1,393,723,683.0046.1x-26.8x2.4x
Sun, 12 Nov 2023SEK 31.2bSEK 15.4b-SEK 1,256,647,710.0034x-24.8x2x
Tue, 10 Oct 2023SEK 25.6bSEK 15.1b-SEK 1,134,516,711.0036.6x-22.6x1.7x
Thu, 07 Sep 2023SEK 29.6bSEK 15.1b-SEK 1,133,372,831.0036.6x-26.1x2x
Sat, 05 Aug 2023SEK 32.1bSEK 15.1b-SEK 213,871,038.0046.7x-150.2x2.1x
Mon, 03 Jul 2023SEK 36.5bSEK 14.6b-SEK 172,476,038.0036.1x-211.7x2.5x
Wed, 31 May 2023SEK 39.0bSEK 14.6b-SEK 173,602,038.0039.4x-224.6x2.7x
Fri, 28 Apr 2023SEK 35.0bSEK 14.5b-SEK 110,425,459.0034x-316.9x2.4x
Sun, 26 Mar 2023SEK 31.9bSEK 14.6b-SEK 57,185,459.0031x-557.6x2.2x
Tue, 21 Feb 2023SEK 41.8bSEK 14.4bSEK 826.4m36.4x50.6x2.9x
Thu, 19 Jan 2023SEK 40.3bSEK 14.2bSEK 943.9m38.7x42.7x2.8x
Price to Earnings Ratio

42.7x


Total Market Cap: SEK 40.3bTotal Earnings: SEK 943.9mTotal Revenue: SEK 14.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Life Sciences Industry Price to Earnings3Y Average -18.6x202420252026
Current Industry PE
  • Investors are pessimistic on the Swedish Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 2.5x is higher than the industry's current PS ratio of 2.1x.
Past Earnings Growth
  • Total earnings for the Life Sciences industry have declined over the last three years, with the industry now making a loss overall.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market2.44%
Healthcare3.40%
Life Sciences2.36%
Clinical Research and Equipment2.36%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ALIF B AddLifeSEK 155.403.1%
+SEK 560.6m		15.5%PE48.1x
MCAP MedCapSEK 548.002.6%
+SEK 211.1m		-7.7%PE42x
GENO Genovis AB (publ.)SEK 21.603.6%
+SEK 49.5m		-10.4%PE67.4x

Latest News

ALIF B
SEK 155.40
AddLife
7D
3.1%
1Y
15.5%

ALIF B: Stable Margins And Refined Discount Rate Will Support Future Upside Potential

Analysts have kept their fair value estimate for AddLife steady at SEK 208.50, with small tweaks to inputs like the discount rate and assumed future P/E reflecting fine tuning of their valuation approach, rather than a fundamental shift in their view of the company. Valuation Changes Fair Value Estimate unchanged at SEK 208.50 per share, indicating no revision to the overall target level.
MAGLE
SEK 15.90
Magle Chemoswed Holding
7D
-7.6%
1Y
-56.6%
IDLDX
SEK 0.33
IDL Diagnostics
7D
-9.8%
1Y
-18.4%
MCAP
SEK 548.00
MedCap
7D
2.6%
1Y
-7.7%
BICO
SEK 19.22
BICO Group
7D
-1.7%
1Y
-33.0%

Little Excitement Around BICO Group AB (publ)'s (STO:BICO) Revenues

Dec 02
Little Excitement Around BICO Group AB (publ)'s (STO:BICO) Revenues
PRO
SEK 14.70
Promimic
7D
-2.0%
1Y
-30.3%
GENO
SEK 21.60
Genovis AB (publ.)
7D
3.6%
1Y
-10.4%

Genovis AB (publ.)'s (STO:GENO) Weak Earnings May Only Reveal A Part Of The Whole Picture

Nov 15
Genovis AB (publ.)'s (STO:GENO) Weak Earnings May Only Reveal A Part Of The Whole Picture
PEXA B
SEK 0.23
PExA
7D
-1.7%
1Y
-40.4%
ATANA
SEK 0.008
Attana
7D
-11.1%
1Y
33.3%
LEVBIO
SEK 0.30
Level Bio
7D
-9.0%
1Y
21.6%